期刊文献+

多发性骨髓瘤患者81例细胞及分子遗传学研究 被引量:1

The cytogenetic and molecular genetic study of 81 multiple myeloma patients
原文传递
导出
摘要 目的 探讨多发性骨髓瘤(MM)患者遗传学特征,评价添加细胞因子及延长培养时间对MM染色体核型分析的影响和间期荧光原位杂交(FISH)检测RB1与P53基因缺失的意义.方法 采用骨髓24h短期培养和G显带技术对81例MM患者进行染色体核型分析,其中28例患者同时采用添加IL-6(终浓度10 μg/L)和重组粒-巨噬细胞集落刺激因子(GM-CSF,终浓度40 μg/L)的6d培养法后的G显带核型分析,31例患者采用间期FISH方法检测RB1与P53基因缺失.结果 81例患者中有75例患者有足够可供分析的中期分裂象,其中31例(41.3%)检出异常克隆.在31例检出染色体异常核型的患者中,单纯染色体数目异常4例(12.9%),单纯染色体结构异常11例(35.5%),染色体数目和结构异常同时存在16例(51.6%).28例患者同时采用两种培养方法对照研究结果显示,骨髓24h短期培养法异常克隆检出率为25.0%,添加细胞因子的6d延期培养法异常克隆检出率为51.9% (P =0.026).31例患者间期FISH结果显示RB1基因缺失10例(32.3%),P53基因缺失11例(35.5%),5例患者RBI和P53基因均缺失.结论 MM染色体核型异常半数以上为染色体数目和结构异常同时存在,显带技术是遗传学检测的基础,添加细胞因子的长期培养法可提高显带技术的异常克隆检出率,间期FISH是一种检测MM患者骨髓瘤细胞基因缺失的敏感方法,具有临床应用价值. Objective To explore the cytogenetic characteristics of multiple myeloma (MM) patients,to evaluate the effect of a long-term culture stimulated by cytokines on cytogenetic study of MM,and to investigate the clinical detection value of RB1 and P53 deletion in interphase plasma cells by using fluorescence in situ hybridization (FISH).Methods Karyotype analysis was performed in 81 MM patients by using the short-term culture of bone marrow cell and G-banding technique.Among the 81 MM patients,28 patients used two culture methods:one was the short-term culture and the other was to culture cells for 6 days with recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) (40 μg/L) and IL-6 (10 μg/L).RB1 and P53 deletion were detected on interphase plasma cells by using FISH in 31 patients.Results Among the 81 patients,75 had enough metaphases for analysis.Among the 75 patients,31 (41.3%) had clonal karyotypic abnormalities including 4 numeric abnormalities,11 structural abnormalities and 16 both abnormalities.Among the 28 patients using two culture methods,the clonal karyotypic abnormalities were detected in 6 patients(25.0% ) in the group of cultured for 24 hours,and 14 patients (51.9%) in 6-day culture group with a significant difference (P =0.026).RB1 deletion and P53 deletion were detected in 10 patients (32.3% ) and 11 patients(35.5% ),respectively,with both RB1 and P53 deletions be detected in 5 patients ( 16.1% ).Conclusions More than half of the tested MM patients have both numeric and structural chromosome abnormalities.The karyotype analysis using banding technique is basic cytogenetic study.Extended culture in the presence of IL-6 and GM-CSF could improve the efficiency of cytogenetic analysis to MM.Interphase FISH is a sensitive method of clinical application significance to detect the gene deletion of MM.
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第12期1039-1042,共4页 Chinese Journal of Internal Medicine
关键词 多发性骨髓瘤 细胞遗传学 原位杂交 荧光 染色体显带 Multiple myeloma Cytogenetics In situ hybridization, fluorescence Chromosome banding
  • 相关文献

参考文献8

  • 1Stewart AK,Bergsagel PL,Greipp PR,et al.A practical guide to defining high-risk myeloma for clinical trials,patient counseling and choice of therapy.Leukemia,2007,21:529-534.
  • 2Facon T,Lai JL,Nataf E,et al.Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma:a report on46 patients.BrJ Haematol,1993,84:743-745.
  • 3张艳,江滨,黄晓军,师岩,何琦,党辉,邱镜滢,陆道培.多发性骨髓瘤的细胞遗传学研究[J].中国实验血液学杂志,2007,15(1):76-78. 被引量:20
  • 4Nilsson T,Lenhoff S,Turesson I,et al.Cytogenetic features of multiple myeloma:impact of gender,age,disease phase,culture time,and cytokine stimulation.Eur J Haematol,2002,68:345-353.
  • 5Fonseca R,Barlogie B,Bataille R,et al.Genetics and cytogenetics of multiple myeloma:a workshop report.Cancer Res,2004,64:1546-1558.
  • 6Avet-Loiseau H,Attal M,Moreau P,et al.Genetic abnormalities and survival in multiple myeloma:the experience of the Intergroupe Francophone du Myé1ome.Blood,2007,109:3489-3495.
  • 7Shaughnessy J,Jacobson J,Sawyer J,et al.Continuous absence of metaphase-defined cytogenetic abnormalities,especially of chromosome 13 and hypodiploidy,ensures long-term survival in multiple myeloma treated with Total Therapy Ⅰ:interpretation in the context of global gene expression.Blood,2003,101:3849-3856.
  • 8魏道林,秦尤文,王椿,颜式可,高彦荣,蔡琦.多发性骨髓瘤患者13号染色体长臂部分缺失及其临床意义[J].中华内科杂志,2006,45(3):217-220. 被引量:3

二级参考文献14

  • 1Desikan R,Barlogie B,Sawyer J,et al.Results of high-dose therapy for 1000 patients with multiple myeloma:durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.Blood,2000,95:4008-4010.
  • 2Avet-Loiseau H,Facon T,Grosbois B,et al.Oncogenesis of multiple myeloma:14q32 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history,immunological features,and clinical presentation.Blood,2002,99:2185-2191.
  • 3Shaughnessy J Jr,Tian E,Sawyer J,et al.Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma:early results of total therapy Ⅱ.Br J Haematol,2003,120:44-52.
  • 4张之南,沈悌,主编.血液病疗效及诊断标准.第2版.北京:科学出版社,1998.373-380.
  • 5Blade J,Samson D,Reece D,et al.Criteria for evaluating response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation.Myeloma subcommittee of the EBNT.European Group for Blood and Marrow Transplant.Br J Haematol,1998,102:1115-1123.
  • 6Jacobsson B,Bernell P,Arvidsson I,et al.Classical morphology,esterase cytochemistry,and interphase cytogenetics of peripheral blood and bone marrow smears.J Histochem Cytochem,1996,44:1303-1309.
  • 7Debes-Marum CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003 ; 17:427 - 436
  • 8Lai JL, Zandecki M, Mary JY, et al. Improved cytogenetics in multiple myeloma:a study of 151 patients including 117 patients at diagnosis. Blood, 1995 ; 85:2490 - 2497
  • 9Harrison C J, Mazzullo H, Cheung KL, et al. Cytogenetics of multiple myeloma:interpretation of fluorescence in situ hybridization resuits. Br J Haematol, 2003; 120:944 -952
  • 10Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood, 2002; 99:2185-2191

共引文献21

同被引文献8

  • 1Chapman MA,Lawrence MS,Keats JJ,et al.Initial genome sequenc- ing and analysis of multiple myeloma[J].Nature, 2011,471 ( 7339 ) : 467 - 472.
  • 2L6pez-Corral L,Guti6rrez NC,Vidriales MB,et al.The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells[J].Clin Cancer Res,2011,17(7) : 1692-1700.
  • 3Rajkumar SV, Gupta V, Fonseca R,et al.lmpact of primary molec- ular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma[J].Leukemia, 2013,27 ( 8 ) : 1738-1744.
  • 4Bergsagel PL, Mateos MV, Gutierrez NC, et al.Improving overall survival and overcoming adverse prognosis in the treatment of cytoge- netically high-risk multiple myeloma[J].Blood,2013,121 (6) :884-892.
  • 5Chang H,Qi C,Yi QL,et al.p53 gene deletion detected by fluores- cence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation[J]. Blood, 2005,105 ( 1 ) :358-360.
  • 6Shaughnessy JD,Zhan F,Burington BE,et al.A validated gene expression model of high-risk multiple myeloma is defined by deregu- lated expression of genes mapping to chromosome l[J].Blood,2007,109 (6) : 2276-2284.
  • 7李倩,安刚,李承文,徐燕,邓书会,刘旭平,齐军元,王亚非,邹德慧,赵耀中,邱录贵.染色体13q14缺失在多发性骨髓瘤发生发展中的意义及对其临床预后的影响[J].中华血液学杂志,2011,32(4):217-220. 被引量:10
  • 8陈丽娟,屈晓燕,李建勇.大力推进多发性骨髓瘤分子细胞遗传学规范化检测进程[J].中华血液学杂志,2013,34(4):290-291. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部